PMID: 7083453Jan 1, 1982Paper

Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice

Cancer Chemotherapy and Pharmacology
T ColomboM D'Incalci

Abstract

The pharmacokinetics of VP16 have been investigated in Lewis lung bearing mice after i.v. doses of 13 and 40 mg/kg. At both doses the plasma elimination of half-life was around 30 min. The lowest VP16-213 levels were in brain and primary tumor. Drug concentrations were much higher in metastases than in primary tumor. The highest concentrations were in small intestine, liver and kidney. Drug levels in the liver were disproportionally higher after 40 mg/kg, and AUC value being approximately 12 times greater than after 13 mg/kg. Urinary excretion of VP16-213 as unchanged drug accounted for 20-30% of the administrated dose in the 60 h after treatment. The concentration cytotoxicity curve was very steep and apparently similar for cells derived from primary tumor or metastases grown in vitro.

Citations

Jan 1, 1991·Cancer Chemotherapy and Pharmacology·N NiederleC G Schmidt
Jan 1, 1987·Chemico-biological Interactions·A G KatkiB K Sinha
Jun 6, 2000·Advanced Drug Delivery Reviews· de Lange ECD D Breimer
Sep 1, 1988·Antimicrobial Agents and Chemotherapy·W CalameR van Furth
Mar 6, 2012·Molecular Cancer Therapeutics·Chaoxin HuAlex Sparreboom
Dec 20, 2013·Biological & Pharmaceutical Bulletin·Makoto MiyazakiMasawo Kakemi
Jul 3, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M RocchettiI Poggesi
Apr 1, 1988·European Journal of Cancer & Clinical Oncology·O K SchlappackG G Steel
Apr 1, 1982·European Journal of Cancer & Clinical Oncology·M D'IncalciL Morasca
Jan 1, 1983·Annals of the New York Academy of Sciences·S Garattini
May 14, 2004·Clinical Pharmacokinetics·Giuseppe ToffoliMauro Boiocchi
Apr 1, 1985·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T ColomboA Guaitani
Jan 1, 1985·Critical Reviews in Toxicology·S Garattini
Nov 22, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Theodore S JohnsonMichael B Jordan

Related Concepts

Riboposid
Malignant Neoplasm of Lung
Mice, Inbred C57BL
Neoplasms, Experimental
Condyline
Drug or Chemical Tissue Distribution

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.